Healthcare Financial News

Subscribe to enjoy similar stories.Apollo Hospitals Enterprise Ltd (AHEL), the country’s largest listed hospital chain by beds, is betting on its planned capacity expansion as well as its clinical programmes and expertise to maintain its lead in an increasingly competitive private healthcare market, its top management said.The hospital chain, which commissioned four hospitals in Pune, Kolkata, Hyderabad and Delhi in FY26, plans to add about 1,500 beds in the next 12-18 months. This includes beds in the new hospitals as well as existing ones.“We think capacity is a strategically important lever… it will place us as the largest player substantially in terms of bed capacity.

Subscribe to enjoy similar stories.MUMBAI: India’s listed electronics manufacturers are under pressure to defend profitability as the mobile-phone assembly boom slows, prompting a shift towards higher-value industrial electronics.Investors remained jittery through the last fiscal, driven by concerns that slowing consumer sentiment could weigh on the rapid growth that electronics manufacturing services (EMS) firms have delivered so far.In an interview with Mint, Jasbir Singh Gujral, managing director of Syrma SGS Technology Ltd, India’s second-largest listed EMS firm, said, “We’re increasingly looking to capture a larger chunk of contracts from defence, aerospace and med-tech verticals, all of which represent opportunities for original design manufacturing, and also bring significantly higher margins. We’ve already started this transition, and we plan to do more of it this fiscal.”Beyond mobile phones and laptops, EMS firms are expanding into smart metres for electricity boards, aerospace and defence subsystems, railway safety instrumentation, printed circuit boards and display assemblies, and medical devices deployed in hospitals.India’s annual mobile phone shipments have remained subdued since the covid-19 pandemic, with industry estimates pointing to a single-digit decline this calendar year from 152 million smartphones shipped last year.The margin pressure driving this shift is increasingly visible.In FY26, Syrma SGS reported an operating margin of 7.1%, up 2.3 percentage points.

Subscribe to enjoy similar stories.Bengaluru: For Bengaluru-based techie Sumukh S, blood tests used to be a transactional matter. He would compare prices across apps, check availability and book whichever lab seemed cheapest or quickest that day. That changed about two years ago, after a friend recommended Orange Health Labs.

Subscribe to enjoy similar stories.Stock market recap: Indian equity markets showed resilience on 14 May, with the Nifty 50 rising 1.18% to close at 23,689.60 despite early volatility. Market breadth remained positive, with 1,725 gainers outpacing 1,540 decliners.Sectoral performance was largely bullish.

Subscribe to enjoy similar stories.New Delhi: Roche Pharma India has launched Tecentriq SC (atezolizumab), the country’s first subcutaneous, or under-the-skin, immunotherapy for lung cancer, the company said on Thursday. This breakthrough formulation marks a significant shift in oncology care, reducing treatment administration time from several hours of conventional intravenous (IV) infusion to just seven minutes.Approved by the Drugs Controller General of India (DCGI) around two months ago for adjuvant and metastatic non-small cell lung cancer (NSCLC), Tecentriq SC is now available across India with more than 100 patients already on immunotherapy.The launch comes at a time when India grapples with a rising cancer burden.

Subscribe to enjoy similar stories.New Delhi: Relief may be in sight for those weary of steep doctor fees and billing discrepancies at private hospitals. India is looking to regulate fees for consultation and common medical procedures at private healthcare facilities with range-bound limits, said two government officials in the know.

Subscribe to enjoy similar stories.New Delhi: Syrma SGS Technology Ltd. expects revenue to grow 30% in the ongoing fiscal, driven by strong demand in automotive and healthcare electronics, even as weakness in consumer electronics and geopolitical uncertainty weigh on the wider electronics manufacturing sector,“We’re expecting our automotive and med-tech verticals to do very well this fiscal, just like what we saw last fiscal,” Managing Director Jasbir Singh Gujral told Mint in an interview on Tuesday.

Subscribe to enjoy similar stories.Healthcare jobs are keeping the U.S. labor market humming.

Subscribe to enjoy similar stories.Dabur India Ltd’s March quarter (Q4FY26) numbers are steady, but not particularly exciting for a company that trades at relatively high valuations. Consolidated revenue grew 7.3% year-on-year to ₹3,038 crore, while full-year FY26 growth stood at 5% to ₹13,193 crore.Ebitda margin was flat year-on-year at 15.2% in Q4FY26. The quarter reflects that Dabur is still trying to find a stronger growth trajectory.

Subscribe to enjoy similar stories.Tamil Nadu and Kerala are among India’s most socially advanced states, with new governments ready to take charge. They are faced with a more complex challenge than many parts of the world that are still grappling with basic developmental deficits.How do they maintain prosperity, create more economic resilience and generate the next wave of opportunity?The numbers tell a powerful story.

Subscribe to enjoy similar stories.BENGALURU/MUMBAI: Blackstone-owned Mphasis Ltd has filed a lawsuit in a US court against rival Coforge Ltd, accusing the Noida-based IT services firm of hiring its employees in violation of contractual restrictions and gaining access to confidential client information.The Bengaluru-based company, which reported $1.8 billion in revenue last year, has also named its former vice president Brijesh Khergamker as a party in the case filed in a Colorado court.

Subscribe to enjoy similar stories.Artificial intelligence (AI) is changing finance, but its most important impact may not be on stock exchanges or global asset managers. It may be on the bank account of a 25-year-old Indian professional.The next big disruption in wealth creation is personal, not institutional. It is about how young earners budget, save, invest and avoid mistakes.

Subscribe to enjoy similar stories.India’s weight-loss frenzy is under the scanner, with the blockbuster drug semaglutide facing fresh scrutiny after hundreds of suspected complications were flagged, said two government officials in the know, with medical experts noting that about half the users report some side-effects. The ongoing review could lead to tighter norms, including label changes, safety warnings and stricter prescription rules.Amid the hype surrounding these glucagon-like peptide-1 (GLP-1) receptors' efficacy for weight loss, the government has documented around 400 reports of adverse drug reactions (ADRs) potentially linked to the medication that is now being clinically evaluated, the officials said.

Subscribe to enjoy similar stories.New Delhi: India is set to implement a new framework for fire and life safety across all healthcare facilities, moving beyond general building codes to address the specific vulnerabilities of patients and critical care units.The ministry of health and family welfare (MoHFW) has released a comprehensive manual titled “National Guidelines on Fire and Life Safety in Healthcare Facilities (2026)” in the backdrop of recurring tragedies that highlight systemic safety failures in Indian healthcare.The manual provides a technical and operational roadmap to identify high-risk zones such as ICUs, operation theatres, and oxygen storage areas for targeted interventions. Under these guidelines, all major structural elements in new hospitals must be non-combustible, and existing buildings must maintain compartmentation to limit the spread of fire and smoke.The updated framework responds to a history of tragic incidents where electrical faults—specifically short circuits and malfunctioning equipment—were identified as the primary cause of hospital fires, exacerbated by high oxygen concentrations and limited patient mobility.In 2021, an oxygen leak at Dr.

Subscribe to enjoy similar stories.MUMBAI: Global investment firm Carlyle has acquired a majority stake in Knack RCM and EqualizeRCM, two US-based healthcare revenue cycle management (RCM) providers, the companies said in a statement on Monday, as it looks to build an artificial intelligence (AI)-led platform in the US healthcare RCM market.The transaction combines two complementary RCM operators to create what the companies described as an AI-native, multi-specialty platform serving physician groups, rural hospitals and durable medical equipment (DME) providers.Financial terms of the transaction were not disclosed.“The US healthcare revenue cycle market is growing rapidly, driven by margin compression, workforce shortages, and the shift to value-based care,” said Kapil Modi, Partner at Carlyle India Advisors. “We believe Knack and Equalize stand out as leaders with their AI-native, specialty‑focused, and outcomes‑driven approach, which aligns well with the growing needs and demand in healthcare RCM.”The combined entity is expected to expand scale and delivery footprint across the US, India and the Philippines, while deepening capabilities in automation and analytics, the company said.Carlyle said it intends to pursue additional acquisitions to build out the platform, underscoring a consolidation strategy in a sector that remains highly fragmented.“One of the core tenets of this investment is to build a scaled, strategically attractive physician and rural hospital RCM platform in a fragmented industry.

Subscribe to enjoy similar stories.Aster DM Healthcare is charting an aggressive expansion and growth roadmap, as it nears completion of its merger with Blackstone-backed Quality Care. With a strong financial and operational outlook for FY27, the combined entity targets over 4,400 additional beds in the next three to four years, managing director Alisha Moopen told Mint in an interview.The merger is expected to be complete in the current quarter ending June, well over a year after the deal was announced in November 2024.

Subscribe to enjoy similar stories.The Centre plans to mandate that doctors and specialists display their consultation fees in English and regional languages, along with their qualifications and registration numbers, according to two government officials and documents reviewed by Mint.The plan also involves mandating a minimum consultation room size of 70 square feet and requiring clinics to stock emergency drugs, including aspirin, adrenaline injections, isosorbide dinitrate for angina (chest pain), diazepam for anxiety and seizures, dexamethasone for inflammatory conditions and severe allergies, and atropine for slow heart rate, among others, through amendments to the Clinical Establishments Rules.The plan covers a broad range of facilities, outlining minimum standards for consultation clinics, clinics with dispensaries, establishments with diagnostic support services, and those offering observation or short-stay care, as well as collection centres and mortuaries.To be sure, there are approximately 43,486 private healthcare facilities and 1,386,136 doctors in India, according to the National Medical Commission (NMC).Every clinic and polyclinic must display a prominent signboard at its entrance, showing operating hours and a clear list of services offered, according to the draft Clinical Establishments Amendment Rules, 2026, reviewed by Mint.The draft calls for strict spatial requirements to ensure patient safety and comfort. For a standard consultation clinic, the government has proposed a minimum carpet area of 35 square feet for the reception and waiting area.

Subscribe to enjoy similar stories.Nearly 70% of Indians lack meaningful health insurance. Our penetration rate— just 0.35% of GDP—is lower than that of China, Hong Kong and Taiwan. The conventional explanation is that Indians either do not understand insurance or cannot afford it.

Subscribe to enjoy similar stories.The impossible trinity, or trilemma, holds that a country cannot simultaneously maintain a fixed exchange rate, free capital movement, and an independent monetary policy; policymakers must prioritise two at the expense of the third.A strikingly similar trilemma sits at the heart of health insurance: the insurer’s duty to settle claims sustainably, the hospital’s duty to deliver effective, patient-centred care while earning a fair return, and the customer’s demand for affordability. Like the economic trilemma, this cannot be resolved by decree.

Subscribe to enjoy similar stories.Wu Jingliang, a human resources manager in Beijing, got a raise at the beginning of the year, and the first financial move her family made was to increase their monthly savings rate.“I don’t dare spend, because I have a child. The child will need schooling later, and then there’s marriage or buying a home—we definitely need to save up a sum of money for him,” she told Barron’s in a phone interview.Conversations with other Chinese consumers revealed similar caution, all relating to feelings of financial insecurity.Beijing keeps rolling out consumption stimulus, and Chinese consumers keep responding with less enthusiasm than policymakers hoped.

Subscribe to enjoy similar stories.The government has set up an inter-ministerial advisory body, the AI Governance and Economic Group (Aigeg), to act as a central node for shaping and coordinating policy on artificial intelligence. But what rules are startups currently operating under, and will this new body change anything for innovation in the space? Mint breaks it down.For startups operating in AI in India today, the legal landscape is a combination of multiple laws.